Anti-Rubella Immunoglobulin G Proficiency Testing Results Suggest Consistent Manufacturer Differences and Opportunity for Harmonization
Arch Pathol Lab Med
.
2024 Aug 1;148(8):862-863.
doi: 10.5858/arpa.2024-0038-LE.
Authors
Rebecca S Treger
1
,
Thomas C Long
2
,
Sally L Calvey
3
,
Danyel H Tacker
4
,
Kamran Kadkhoda
5
6
,
Mark H Wener
1
7
,
Susan L Fink
1
Affiliations
1
Department of Laboratory Medicine & Pathology, University of Washington, Seattle.
2
Department of Biostatistics, Surveys, College of American Pathologists, Northfield, Illinois.
3
Department of Laboratory Improvement Programs, Surveys, College of American Pathologists, Northfield, Illinois.
4
Department of Pathology, Anatomy, and Laboratory Medicine, West Virginia University, Morgantown.
5
Immunopathology Laboratory, Robert Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio.
6
Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio.
7
Rheumatology Division, Department of Medicine, University of Washington, Seattle.
PMID:
39069306
DOI:
10.5858/arpa.2024-0038-LE
No abstract available
Publication types
Letter
MeSH terms
Humans
Immunoglobulin G* / analysis
Immunoglobulin G* / blood
Laboratory Proficiency Testing*
Substances
Immunoglobulin G